ASTM F 1635 : 2024
Current
The latest, up-to-date edition.
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants
Hardcopy , PDF
English
01-12-2024
Committee |
F 04
|
DocumentType |
Test Method
|
Pages |
8
|
PublisherName |
American Society for Testing and Materials
|
Status |
Current
|
Supersedes |
1.1This test method covers in vitro degradation of hydrolytically degradable polymers (HDP) intended for use in surgical implants. It provides a detailed methodology for conditioning samples and suggests quantitative techniques for evaluating changes in properties (for example, mass, molar mass, and mechanical strength) over time.
1.1.1For many types of HDPs, a correlation has been established between in vitro degradation per this practice and in vivo degradation for unloaded specimens (see X1.1.1).
1.2The requirements of this test method apply to HDPs in various forms:
1.2.1Virgin polymer resins, or
1.2.2Any form fabricated from virgin polymer such as a semi-finished component of a finished product, a finished product, which may include packaged and sterilized implants, or a specially fabricated test specimen.
1.2.2.1Use of this test method for conditioning virgin resins, semi-finished forms, or special test specimens may provide information that is useful for material and/or product development. However, those results are not sufficient for predicting the degradation behavior of the final, sterilized implant. Subsections 5.5, 8.2, and X1.2 provide additional guidance.
1.3This standard provides guidance for mechanical loading or fluid flow, or both, when relevant to the device being evaluated. The specifics of loading type, magnitude, and frequency for a given application are beyond the scope of this test method.
1.4This standard is not applicable to conditioning of polymers that degrade primarily through mechanisms other than hydrolysis (for example, enzymatic or oxidative degradation). See X1.1.1 for more information.
1.5The values stated in SI units are to be regarded as standard. No other units of measurement are included in this standard.
1.6This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety, health, and environmental practices and determine the applicability of regulatory limitations prior to use.
1.7This international standard was developed in accordance with internationally recognized principles on standardization established in the Decision on Principles for the Development of International Standards, Guides and Recommendations issued by the World Trade Organization Technical Barriers to Trade (TBT) Committee.
ASTM F 2902 : 2024 | Standard Guide for Assessment of Absorbable Polymeric Implants |
ASTM F 3659 : 2024 | Standard Guide for Bioinks Used in Bioprinting |
ASTM F 3260 : 2018 | Standard Test Method for Determining the Flexural Stiffness of Medical Textiles |
ASTM F 2150 : 2019 | Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products |
ASTM F 3274 : 2021 | Standard Guide for Testing and Characterization of Alginate Foam Scaffolds Used in Tissue-Engineered Medical Products (TEMPs) |
ASTM F 3510 : 2021 | Standard Guide for Characterizing Fiber-Based Constructs for Tissue-Engineered Medical Products |
ASTM F 561 : 2019 | Standard Practice for Retrieval and Analysis of Medical Devices, and Associated Tissues and Fluids |
ASTM F 2502 : 2024 | Standard Specification and Test Methods for Absorbable Plates and Screws for Internal Fixation Implants |
ASTM F 3223 : 2017 | Standard Guide for Characterization and Assessment of Tissue Engineered Medical Products (TEMPs) for Knee Meniscus Surgical Repair and/or Reconstruction |
ASTM F 3225 : 2017 : R2022 | Standard Guide for Characterization and Assessment of Vascular Graft Tissue Engineered Medical Products (TEMPs) |
ASTM F 1983 : 2023 | Standard Practice for Assessment of Selected Tissue Effects of Absorbable Biomaterials for Implant Applications |
ASTM F 2224 : 2009 : R2020 | Standard Specification for High Purity Calcium Sulfate Hemihydrate or Dihydrate for Surgical Implants |
ASTM F 2027 : 2016 | Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
ASTM F 3036 : 2021 | Standard Guide for Testing Absorbable Stents |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.